ACADIA Pharmaceuticals, Inc. Reports Third Quarter 2013 Financial Results
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.